April19 Discovery
www.april19.aiWe use next-gen machine learning to find novel psychedelic drug compounds. Classical (first-generation) psychedelics have never been optimized to treat any disease and so we aim to design compounds with the optimal risk-benefit ratio in various indications. Beyond mental health, we focus on neurodegenerative, neural injuries and other less-studied indications.
Read more
We use next-gen machine learning to find novel psychedelic drug compounds. Classical (first-generation) psychedelics have never been optimized to treat any disease and so we aim to design compounds with the optimal risk-benefit ratio in various indications. Beyond mental health, we focus on neurodegenerative, neural injuries and other less-studied indications.
Read more
Country
City (Headquarters)
London
Industry
Employees
1-10
Founded
2020
Social
Employees statistics
View all employeesPotential Decision Makers
Co - Founder
Email ****** @****.comPhone (***) ****-****
Technologies
(8)
Reach decision makers at April19 Discovery
Free credits every month!
April19 Discovery FAQ
London, United Kingdom
Pharmaceutical Manufacturing
